HBCO — Hofseth BioCare ASA | ScreenerHero

HBCOHofseth BioCare ASA

OSL · NO · Health Care · Biotechnology

1.300NOKMkt Cap: —P/E: —Last update: 2026-05-08

Industry Peers

Biotechnology

103.39BDKKP/E 20.1

45.12BEURP/E 29.5

Camurus AB (publ)

30.32BSEKP/E 44.9

BioArctic AB (publ)

28.78BSEKP/E 28.2

Zealand Pharma A/S

21.93BDKKP/E 3.5

Bavarian Nordic A/S

14.40BDKKP/E 12.5

Financière de Tubize SA

8.83BEURP/E 95.3

loading…

Indicators:|

Key Statistics

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

P/B—

P/S—

EV/EBITDA—

EV/Revenue—

EPS (TTM)—

EPS (Forward)—

Cash Flow & Leverage

FCF Yield—

FCF Margin—

Operating CF—

CapEx (TTM)—

Net Debt/EBITDA—

Net Debt—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg—

Avg Vol (30d)5.36K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

52W Range

—

52W High1.300 NOK

52W Low1.300 NOK

Profitability

Gross Margin—

EBITDA Margin—

Profit Margin—

Oper. Margin—

ROE—

ROA—

Revenue Growth—

Earnings Growth—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate—

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Fiscal Year End—

MR Quarter—

Employees—

Last Price1.300 NOK

CountryNO

SectorHealth Care

IndustryBiotechnology

ISIN—